Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.1.9
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
COSTS AND EXPENSES:    
Research and development $ 1,643,994us-gaap_ResearchAndDevelopmentExpense $ 1,715,307us-gaap_ResearchAndDevelopmentExpense
General and administrative 943,433us-gaap_GeneralAndAdministrativeExpense 1,087,035us-gaap_GeneralAndAdministrativeExpense
Restructuring costs 0us-gaap_RestructuringCosts 16,882us-gaap_RestructuringCosts
Total costs and expenses 2,587,427us-gaap_CostsAndExpenses 2,819,224us-gaap_CostsAndExpenses
LOSS FROM OPERATIONS (2,587,427)us-gaap_OperatingIncomeLoss (2,819,224)us-gaap_OperatingIncomeLoss
OTHER INCOME (EXPENSE):    
Gain (loss) on revaluation of derivative warrants 288,251us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet (54,945)us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
Interest expense, net (1,980)us-gaap_InterestIncomeExpenseNonoperatingNet (69,244)us-gaap_InterestIncomeExpenseNonoperatingNet
Total other income (expense), net 286,271us-gaap_NonoperatingIncomeExpense (124,189)us-gaap_NonoperatingIncomeExpense
NET LOSS $ (2,301,156)us-gaap_NetIncomeLoss $ (2,943,413)us-gaap_NetIncomeLoss
BASIC AND DILUTED NET LOSS PER COMMON SHARE (in dollors per share) $ (0.30)us-gaap_EarningsPerShareBasicAndDiluted $ (1.03)us-gaap_EarningsPerShareBasicAndDiluted
SHARES USED IN COMPUTING BASIC AND DILUTED NET LOSS PER COMMON SHARE (in shares) 7,562,762us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 2,869,739us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted